AUTONOMIX MEDICAL, INC. Share-based Payment Arrangement, Accelerated Cost
AUTONOMIX MEDICAL, INC. (AMIX) reported Share-based Payment Arrangement, Accelerated Cost of $3.70 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, accelerated cost for the quarter ending 2026-03-31 was $0.00.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, accelerated cost for the quarter ending 2025-12-31 was $0.00.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, accelerated cost for the quarter ending 2025-09-30 was $3.70M.
- AUTONOMIX MEDICAL, INC. share-based payment arrangement, accelerated cost for fiscal 2026 was $3.70M.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $0.00 derived: sum of 2 quarters · filed 2026-05-27 | $3.70M derived: sum of 3 quarters · filed 2026-08-13 | $3.70M 10-K · filed 2026-05-27 |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $3.70M derived: sum of 2 quarters · filed 2026-08-13 | $3.70M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $3.70M 10-Q · filed 2026-08-13 | $3.70M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |